secwatch.observer — SEC 8-K summary
======================================

Issuer:     Savara Inc (SVRA)
CIK:        0001160308
Form:       8-K
Filed at:   2023-03-30T23:59:59+00:00
Accession:  0001193125-23-085762
Event type: other_material
Sentiment:  neutral
Materiality: 0.25
Item codes: 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Savara amends bylaws to update stockholder proposal and director nomination procedures
--------------------------------------------------------------------------------

- Added updated procedures for stockholder proposals and director nominations, including additional information requirements.
- Requires nominating stockholders to comply with Rule 14a-19 universal proxy rules and use a proxy card color other than white.
- Revised director removal provision: directors may be removed with or without cause by majority vote.
- Added emergency bylaw provision for board quorum during emergencies; updated electronic transmission notice provisions.
- Amendments also reflect name change from Mast Therapeutics to Savara Inc. and conform to recent DGCL changes.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1160308/000119312523085762/0001193125-23-085762-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1160308/000119312523085762/d802113d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-085762

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer